The Programmed Death-1 Immune-Suppressive Pathway: Barrier to Antitumor Immunity
Author:
Publisher
The American Association of Immunologists
Subject
Immunology,Immunology and Allergy
Reference79 articles.
1. Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
2. Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
3. Nivolumab plus Ipilimumab in Advanced Melanoma
4. Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
5. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.;Ishida;EMBO J.,1992
Cited by 186 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. IRnet: Immunotherapy response prediction using pathway knowledge-informed graph neural network;Journal of Advanced Research;2024-08
2. Angiogenesis and Ovarian Cancer: What Potential Do Different Subtypes of Circulating Endothelial Cells Have for Clinical Application?;International Journal of Molecular Sciences;2024-06-06
3. Paracrine- and cell-contact-mediated immunomodulatory effects of human periodontal ligament-derived mesenchymal stromal cells on CD4+ T lymphocytes;Stem Cell Research & Therapy;2024-05-31
4. Identification of Critical Immune Regulators and Potential Interactions of IL-26 in Riemerella anatipestifer-Infected Ducks by Transcriptome Analysis and Profiling;Microorganisms;2024-05-12
5. High immune cell infiltration predicts improved survival in cholangiocarcinoma;Frontiers in Oncology;2024-05-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3